| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |